Skip to content
Annos Wellness

Peptide Therapy

Emerging science. Personalized medicine.

Annos Wellness is developing a personalized peptide therapy program, bringing together emerging research, individualized clinical evaluation, and thoughtful medical oversight.

Treatment options will be determined by clinical appropriateness, applicable regulations, and lawful pharmacy availability.

Explore the science.

Discover six peptides under investigation in tissue repair, metabolism, inflammation, aging biology, and neurological function.

Animal tissue injury studies

BPC-157

Animal studies explore how muscles, tendons, and the lining of the digestive tract heal after injury and what role BPC-157 might play.

Investigational research

Thymosin beta-4 and its fragment

TB-500

Interest in TB-500 comes from research on how its parent protein, thymosin beta-4, helps cells move during tissue repair. The fragment itself is less studied.

Investigational research

Telomere research in cultured cells

Epitalon

Researchers studying cellular aging are exploring how Epitalon affects telomeres, the protective caps on chromosomes, in lab-grown human cells.

Investigational research

Intestinal cell and animal studies

KPV

Researchers are studying whether KPV can calm inflammatory signals in the gut, using intestinal cells and animal models.

Investigational research

Glucose metabolism in cells and mice

MOTS-c

Studies in cells and mice explore how MOTS-c influences the way muscles use blood sugar and respond to insulin.

Investigational research

Neurological research in rats

Semax

Researchers are studying how Semax affects brain signals involved in learning and memory, including in experiments with rats.

Investigational research

BPC-157, 1 of 6

These peptides are investigational and not FDA-approved. Human evidence is limited, and long-term risks remain uncertain.

Read the full disclaimer

The peptides featured are investigational and have not received FDA approval. Research into their potential benefits, safety, and effectiveness is ongoing. Annos Wellness plans to offer individualized peptide therapy, subject to clinical evaluation, applicable regulations, and appropriate pharmacy sourcing.

Human evidence is limited, and long-term risks remain uncertain. Annos has not confirmed a pharmacy source for these options.

A thoughtful approach to peptide therapy.

Individualized evaluation
We would begin with your health history, goals, and clinical needs.
Evidence-informed decisions
You and your clinician would weigh the research, its limits, and established alternatives.
Ongoing medical oversight
Any treatment plan would include appropriate monitoring and follow-up.

What's included

  • Clinical evaluation
  • Individualized treatment planning
  • Ongoing medical oversight

Enrollment is currently closed. Future coverage and lawful availability have not been established.